Showing 1681-1690 of 4065 results for "".
Expert Debate: The Ethics of Consumer Genetic Testing
https://reachmd.com/programs/clinicians-roundtable/expert-debate-ethics-consumer-genetic-testing/9838/Is consumer access to genetic testing, without a doctor's involvement, beneficial or harmful for patients? This debate examines both sides.Uncovering Misperceptions About College Drinking
https://reachmd.com/programs/clinicians-roundtable/uncovering-misperceptions-about-college-drinking/4087/Most of us have fond memories of our college years. As we now see in our families and in our practices, and perhaps retrospectively in ourselves, the behavior of college students is often influenced by what is perceived to be normal among their peers. Looking more specifically at social norms researOptimizing Treatment Pathways in NSCLC: The Role of the Multidisciplinary Team
https://reachmd.com/programs/deep-breaths-updates-chest/optimizing-treatment-pathways-in-nsclc-the-role-of-the-multidisciplinary-team/35981/Effective care for non-small cell lung cancer (NSCLC) now depends on early molecular testing and coordinated input from a variety of specialties. Dr. Gerard Silvestri sits down with Drs. Jessica Donington, Mariam Alexander, and Anurag Singh to review why multidisciplinary integration is critical toCombination Treatment Focused on a Noninvasive Approach to Facial Rejuvenation
https://reachmd.com/topics/energy-based-devices/combination-treatment-focused-on-a-noninvasive-approach-to-facial-rejuvenation/35420/A recipe for predictable skin rejuvenationManaging Mental Health in the Times of Pandemic
https://reachmd.com/programs/covid-19-frontlines/managing-mental-health-in-the-times-of-pandemic/11409/One of the many impacts of the COVID-19 pandemic is the silent spread of anxiety and depression among our patients. How can we help them cope?One Emergency Physician’s Cheat Sheet to COVID-19
https://reachmd.com/programs/covid-19-frontlines/one-emergency-physicians-cheat-sheet-to-covid-19/11376/Tune in to hear an anonymous account of unpredictable COVID-19 symptoms in a small-town emergency room.Non-contraceptive benefits of contraceptives
https://reachmd.com/programs/clinicians-roundtable/non-contraceptive-benefits-of-contraceptives/1609/Our patients remain convinced that the birth control pill increases cancer risk. Yet one of the pill’s unappreciated benefits is the remarkable protection it can afford against ovarian cancer. This is but one of the non-contraceptive benefits of contraceptives that we will explore. You are listeHealth Reform for Non-Partisans: Reflections by Alan Weil, Editor-in-Chief of Health Affairs
https://reachmd.com/programs/conversations-on-health-care/health-reform-for-non-partisans-reflections-by-alan-weil-editor-in-chief-of-health-affairs/6996/This week, Mark and Margaret speak with Alan Weil, Editor-in-Chief of Health Affairs, published by Project HOPE - a leading peer-reviewed journal on health policy thought and research. Before that, Mr. Weil was Executive Director of the National Academy for State Health Policy, a non-partisan organiOnce-Daily Oral Zasocitinib Demonstrates Rapid and Reproducible Skin Clearance with a Consistent Safety Profile in Moderate-to-Severe Plaque Psoriasis: Results from Two Randomized Phase 3 Trials (LATITUDE-PsO-3001 and 3002)
https://reachmd.com/clinical-practice/dermatology/once-daily-oral-zasocitinib-demonstrates-rapid-and-reproducible-skin-clearance-with-a-consistent-safety-profile-in-moderate-to-severe-plaque-psoriasis-results-from-two-randomized-phase-3-trials-latitude-pso-3001-and-3002/56617/Review Phase 3 trial data (LATITUDE-PsO-3001 and 3002) on once-daily oral zasocitinib in moderate-to-severe plaque psoriasis.Early Onset of Response to Zasocitinib (TAK-279), a Highly Selective and Potent TYK2 Inhibitor, Is Correlated With Modulation of TYK2 Signaling and Disease Pathway Biomarkers in Patients With Moderate-to-Severe Plaque Psoriasis
https://reachmd.com/clinical-practice/dermatology/early-onset-of-response-to-zasocitinib-tak-279-a-highly-selective-and-potent-tyk2-inhibitor-is-correlated-with-modulation-of-tyk2-signaling-and-disease-pathway-biomarkers-in-patients-with-moderate-to-severe-plaque-psoriasis/50977/Review phase 2b trial data on zasocitinib in patients with moderate-to-severe plaque psoriasis.